Dermatology Doctors in Paducah, KY Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

Dr. Joseph Allen Blackmon, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3101 Parisa Dr, Paducah, KY 42003 Phone: 270-444-8477    Fax: 270-444-8479

Dr. James Michael Giannini, M. D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2138 Broadway St, Paducah, KY 42001 Phone: 270-444-7248    Fax: 270-444-6014

Halden H Ford, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3101 Parisa Dr, Paducah, KY 42003 Phone: 270-444-8477    Fax: 270-444-8479

Evelyn Montgomery Jones, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2721 W Park Dr, Paducah, KY 42001 Phone: 270-554-7540    Fax: 270-554-0316

News Archive

The WHO didn't reverse its position on kids and Covid vaccines

A social media post circulating on Facebook and Instagram claims that the World Health Organization recently flipped its policy recommendation about children receiving a Covid-19 vaccine.

Gas bubbles used to block oxygen flow to tumors and deliver drugs

The process of blocking blood flow to a tumor is called embolization, and using gas bubbles is a new technique in embolotherapy.

Some large employers contract directly with medical groups to reduce health care costs

Investor's Business Daily on Monday examined how some large employers, such as Sprint Nextel and Waste Management, have begun "cutting the middleman in heath insurance" and have "signed direct-contracting deals with medical groups instead of insurers" to help reduce costs.

Cardin is 'optimistic' that 'super committee' will fix SGR

Sen. Ben Cardin said Wednesday he is optimistic that the super committee will fix the Sustainable Growth Rate formula. "We have to start with a realistic budget baseline," the Maryland Democrat told about 500 National Institutes of Health employees at a town hall meeting on the agency's main campus in Bethesda, Md. Repealing the SGR is estimated to cost about $350 billion over the next decade, but wouldn't have to be offset to meet the super committee's goal of $1.2 trillion if the Bowles-Simpson baseline is used, Cardin said.

Eli Lilly, Alnara sign definitive merger agreement

Eli Lilly and Company and Alnara Pharmaceuticals, Inc. today announced they have signed a definitive merger agreement whereby Lilly will acquire Alnara, a privately held biotechnology company developing protein therapeutics for the treatment of metabolic diseases. Alnara's lead product in development is liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT).

Read more Medical News

› Verified 4 days ago